- Great-West Lifeco’s fourth-quarter Base EPS surpassed expectations at C$1.20, compared to the estimate of C$1.13.
- The company reported a base return on equity of 17.5%.
- Total assets under management reached C$1.04 trillion, while assets under administration totaled C$3.27 trillion.
- Paul Mahon, President and CEO, emphasized the company’s strong earnings momentum and shareholder value creation, reflected in a 10% dividend increase and plans to repurchase additional common shares.
- The results are indicative of successful execution of growth strategies, exceeding medium-term financial goals.
- On the stock recommendation front, the company has 1 buy rating, 7 hold ratings, and 2 sell ratings.
A look at Great-West Lifeco Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 4 | |
| Growth | 3 | |
| Resilience | 3 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Great-West Lifeco Inc. is positioned for a stable long-term outlook according to Smartkarma Smart Scores. With solid ratings across key factors, the company appears well-rounded in its performance. Particularly, its above-average scores for Dividend and Momentum indicate strength in its ability to provide steady returns to investors and maintain positive market momentum.
As a financial services holding company specializing in life insurance, health insurance, investment, and retirement savings, Great-West Lifeco focuses on meeting the financial security needs of individuals in Canada and the United States. Its balanced Smart Scores suggest a company that is reliable in its operations, offering a mix of value, growth, and resilience to weather market fluctuations and deliver consistent performance over the long term.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
